TAMMY DUNN: Open Payments
NPI 1407396146 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,132 in 184 payments from 16 companies in 2025. Trend: 2023 $3,186 · 2024 $2,941 · 2025 $4,132
Food & beverage: $4,132
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $1,063 |
| ABBVIE INC. | 80 | $1,061 |
| Otsuka America Pharmaceutical, Inc. | 19 | $440 |
| Janssen Pharmaceuticals, Inc | 7 | $239 |
| Alkermes, Inc. | 10 | $222 |
| Axsome Therapeutics, Inc. | 4 | $186 |
| Neurocrine BioSciences, Inc. | 2 | $152 |
| Teva Pharmaceuticals USA, Inc. | 10 | $150 |
| Boston Scientific Corporation | 1 | $140 |
| E.R. Squibb & Sons, L.L.C. | 6 | $138 |
Products named: CAPLYTA, VRAYLAR, REXULTI, INVEGA SUSTENNA, ABILIFY MAINTENA, Auvelity, INGREZZA, ARISTADA.
Industry payments across PA — which companies pay providers there.
